摘要
The rapid growth in the biotechnology equity market and the explosion in the number of biotechnology initial public offerings (IPOs)have created unprecedented wealth in the western hemisphere in the form of restricted securities shares(equity)in newly founded companies that can be traded only in compliance with regulations imposed by the relevant authorities.
The rapid growth in the biotechnology equity market and the explosion in the number of biotechnology initial public offerings （IPOs）have created unprecedented wealth in the western hemisphere in the form of restricted securities shares（equity）in newly founded companies that can be traded only in compliance with regulations imposed by the relevant authorities.
出处
《中国医药技术经济与管理》
2008年第1期67-71,共5页
China Pharmaceutical Technology Economics & Management
